8 results
Initial Anticoagulation for Venous Thromboembolism (VTE)

#Anticoagulation #Initial #Initiation #Dosing #Venous #Thromboembolism #VTE #Pharmacology #Table #Management
Initial Anticoagulation ... Thromboembolism (VTE ... Initial #Initiation #Dosing ... #Pharmacology # ... Table #Management
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... #Medications #Pharmacology ... #Dosing #Dosing ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
anticoagulant agents ... #DOAC #Dosing #Oral ... #Anticoagulation ... #Comparison #Table ... #Pharmacology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... adults, <3g in CKD ... avoid NSAIDs if CKD ... steroids, on ASA/anticoagulation ... • Neuropathic agents
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
Fibrillation, VTE ... Prophylaxis, VTE ... recommend alternative agent ... OralAnticoagulant #Anticoagulation ... #Hematology #Pharmacology
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... phosphate binding agents ... since they are not able ... Purposes Only* #CKD ... #Pharmacology #
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation ... #management #algorithm ... #pharmacology # ... #medications #table ... hematology #warfarin #dosing
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... event, follow ACC algorithm ... Anticoagulation ... • <3mo since VTE ... postoperative cardiac events